NO SCALD DPA

Main information

  • Trade name:
  • CHEMLEY NO-SCALD DPA FRUIT DIP LIQUID CONCENTRATE
  • Pharmaceutical form:
  • Emulsifiable
  • Units in package:
  • 5L,19L,209L
  • Class:
  • AgChem
  • Medicine domain:
  • Equipment
  • Medicine type:
  • Agrochemical

Documents

Localization

  • Available in:
  • CHEMLEY NO-SCALD DPA FRUIT DIP LIQUID CONCENTRATE
    Australia
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • APPLE - GOLDEN DELICIOUS - POST HARVEST | APPLE - GRANNY SMITH - POST-HARVEST DIP | APPLE - JONATHAN - POST-HARVEST DIP | APPLE
  • Therapeutic area:
  • PGR
  • Therapeutic indications:
  • SUPERFICIAL SCALD
  • Product summary:
  • For the reduction of superficial scald on apples and pears.See RESTRAINTS on label

Other information

Status

  • Source:
  • Australian Pesticides and Veterinary Medicines Authority (APVMA)
  • Authorization status:
  • Registered and available
  • Authorization number:
  • 30354/0105
  • Authorization date:
  • 11-01-2006
  • Last update:
  • 15-06-2017

Patient Information leaflet: composition, indications, side effects, dosage, interactions, adverse reactions, pregnancy, lactation

There are no safety alerts related to this product.

16-11-2018

Daptomycin Hospira (Hospira UK Limited)

Daptomycin Hospira (Hospira UK Limited)

Daptomycin Hospira (Active substance: daptomycin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)7678 of Fri, 16 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/004310/T/0008

Europe -DG Health and Food Safety

21-9-2018

Scientific guideline:  Reflection paper on resistance in ectoparasites, draft: consultation open

Scientific guideline: Reflection paper on resistance in ectoparasites, draft: consultation open

The Committee adopted a new draft reflection paper on ectoparasitic resistance (EMA/CVMP/EWP/310225/2014) for a 11-month period of public consultation. The reflection paper aims to give an overview of the currently known resistance situation in ectoparasites to active substances used in veterinary medicinal products with a special focus on Europe, and to provide a review of the current knowledge on resistance mechanisms.

Europe - EMA - European Medicines Agency

3-7-2018

Azomyr (Merck Sharp and Dohme B.V.)

Azomyr (Merck Sharp and Dohme B.V.)

Azomyr (Active substance: desloratadine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018) 4253 of Tue, 03 Jul 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/310/T/94

Europe -DG Health and Food Safety